glp-1 alcohol cravings IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target How GLP-1 Medication Reduces Alcohol

Researchers, regulators, and courts have identified a range of severe health risks associated with these drugs, several of which form the basis of the lawsuits now pending against manufacturers Novo Nordisk and Eli Lilly: Gastroparesis: Also known as stomach paralysis, gastroparesis occurs when the stomach muscles weaken to the point that the stomach can no longer empty food into the small intestine at a normal rate

Brain site-specific inhibitory effects of the GLP-1 analogue Exendin-4 on alcohol intake and operant responding for palatable food

Sustained GLP-1 signaling also possesses additional benefits: appetite and concomitant weight reduction, and cardioprotective benefits

73 As with the findings in SH-SY5Y cells, exenatide-induced PC12 cell neurites displayed comparable morphology, although they were slightly shorter in length and smaller in number, with less branching when compared with NGF untreated cells